New York, New York, United States Maxim Group is the famous Corporate Investor, which was founded in 2002. The main department of described Corporate Investor is located in the New York. The venture was found in North America in United States.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight ContraFect, Abeona Therapeutics, BillMyParents. We can highlight the next thriving fund investment areas, such as Young Adults, E-Commerce. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.
The usual cause for the fund is to invest in rounds with 2 partakers. Despite the Maxim Group, startups are often financed by Stop Sanfilippo, George Soros, Equity Source Partners. The meaningful sponsors for the fund in investment in the same round are RBC Capital Markets, Jefferies, H. C. Wainwright & Co.. In the next rounds fund is usually obtained by Venrock, Sofinnova Investments, New Leaf Venture Partners.
The overall number of key employees were 12.
Opposing the other organizations, this Maxim Group works on 11 percentage points more the average amount of lead investments. The high activity for fund was in 2017. The fund is constantly included in less than 2 deals per year. The increased amount of exits for fund were in 2015. Considering the real fund results, this Corporate Investor is 40 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Argoquest | Israel, Tel Aviv, Tel Aviv District |
| Black Fish | China, Jiangsu, Nanjing |
| Blockchain Ventures | California, Palo Alto, United States |
| Geneva Venture Partners | Las Vegas, Nevada, United States |
| Green Campus Innovations | - |
| INCapital Ventures | Canada, Ontario, Toronto |
| Kenetic | China, Hong Kong, Hong Kong Island |
| Lanai Partners | Barcelona, Catalonia, Spain |
| NGK SPARK PLUG CO | Aichi Prefecture, Japan, Nagoya |
| Portage Partners | New York, New York, United States |
| PT. Astra International Tbk - TSO Salemba | Indonesia, Jakarta, Jakarta Raya |
| Rowny Capital | District of Columbia, United States, Washington |
| Runa Capital | California, Palo Alto, United States |
| Shanghai Hongjia Asset Management Co. | China, Shanghai |
| Sutardja Ventures | - |
| Teddy Sagi Group | Cyprus, Nicosia |
| Tianjin Junding Dianlian Qiye Guanli Zixun Zhongxin | China, Tianjin, Wuqing |
| TruePosition | Berwyn, Pennsylvania, United States |
| Zenium Technology Partners(ZTP) | England, London, United Kingdom |
| Zhisland Capital | Beijing, Beijing, China |
Clifford Teller Executive Managing Director - Investment Banking b19dcbd1ce1b feb75c3471893bee30 39e6fc668 f4efe74dbffd703756aa317a419ee106 becda129de6f 29cd97ee5634d336d0616bbc831d821d 0c355eb6dc374c64 c5ee3d3d4655a9d8f4a22083101e5e 7f8244691486e 94c32c9e0b574256b0f01703217e38 
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Nacuity Pharmaceuticals | $16M | 15 Jun 2022 | Fort Worth, Texas, United States | ||
Alveo Technologies | $38M | 05 Jan 2018 | United States, " United States"} | ||
Edge Therapeutics | $18M | 04 Jun 2013 | New Jersey, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Nacuity Pharmaceuticals | $16M | 15 Jun 2022 | Fort Worth, Texas, United States | ||
Alveo Technologies | $38M | 05 Jan 2018 | United States, " United States"} | ||
Edge Therapeutics | $18M | 04 Jun 2013 | New Jersey, United States |
